Skip to main content
. 2023 Sep 18;23:873. doi: 10.1186/s12885-023-11389-x

Table 3.

Multivariate analysis of prognostic factors for overall survival

Variables HR (95% CI) P value
Hepatitis
 Hepatitis B 1
 Other 0.706 (0.457, 1.090) 0.116
ALT (µmol/L) 0.995 (0.987, 1.003) 0.215
Treatment method
 Atez/Bev 1
 TACE-Atez/Bev 0.663 (0.453, 0.969) 0.034

HR Hazard ratio, CI Confidence interval, ALT Alanine aminotransferase, Atez/Bev Atezolizumab/bevacizumab, TACE Transarterial chemoembolization